Q3 2019 Investor Presentation
Market-leading connected health solutions
Pioneering innovations and providing clinical evidence that support
better patient outcomes and improved business efficiencies for customers
AirView™
myAir
TM
85
85
100 points
85
121%
patient adherence
1.
2.
3.
2014
4.
with automated
compliance
coaching 1
Labor
Costs² 159%
New
Patient 155%
Setups³
Hwang, et al., AJRCCM 2017
Munafo, et al. Sleep Breath 2016
Data based on monthly patient setups and compliance rates of DME customers from February
March 2015. Historical results for this provider over the stated time
Crocker, et al., Abstract CHEST 2016
World's largest study for adherence
> 128,000 patients
124%
patient adherence
with patient
engagement4
©2019 ResMed I Q3 2019 Investor Presentation | 47
ResMedView entire presentation